The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment modifications and mortality among female patients with subsequent breast cancer: A report from the Childhood Cancer Survivor Study (CCSS).
 
Lucie Marie Turcotte
No Relationships to Disclose
 
Hasibul Hasan
No Relationships to Disclose
 
Emily Stene
No Relationships to Disclose
 
Sarah Elizabeth Monick
No Relationships to Disclose
 
Ryan Rader
Honoraria - HealthCourse, Inc.; Precisca
 
Jori Sheade
No Relationships to Disclose
 
Heather Renee Wolfe
No Relationships to Disclose
 
Zhanni Lu
No Relationships to Disclose
 
Logan Spector
No Relationships to Disclose
 
Aaron J. McDonald
No Relationships to Disclose
 
Michael A. Arnold
Stock and Other Ownership Interests - General Electric; senseonics
Patents, Royalties, Other Intellectual Property - My wife receives royalties from her medical text book series from Lippincott Williams & Wilkins (I)
 
Chaya S. Moskowitz
No Relationships to Disclose
 
Tara O. Henderson
Consulting or Advisory Role - MITRE Corporation
Other Relationship - Seagen
 
Gregory T. Armstrong
No Relationships to Disclose
 
Yutaka Yasui
No Relationships to Disclose
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Exact Sciences; GE Healthcare; Gilead Sciences; Guardant Health; Merck; Moderna Therapeutics; Novartis; Sanofi; Seagen; Stemline Therapeutics
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Kevin C. Oeffinger
No Relationships to Disclose
 
Joseph Philip Neglia
No Relationships to Disclose
 
Anne Hudson Blaes
Research Funding - Dompé Farmaceutici
 
Cindy Im
No Relationships to Disclose